Thursday , 23 May 2019

Pharmaceuticals

UAE and Saudi pharmaceutical product importers hold fruitful discussions with Brazilian manufacturers in São Paulo

Meeting reflects Arab countries’ growing commitment to strengthen ties with vast South American nation Saudi Arabia and UAE imported a combined USD 3 million worth of pharma products from Brazil in 2015 UAE – The Arab-Brazilian Chamber of Commerce (ABCC) has revealed that major importers of pharmaceutical products from the UAE and the Kingdom of Saudi Arabia held fruitful discussions …

Read More »

Iran’s Pharmaceutical Sector to become a Pharma Powerhouse Post Sanction Era – Biotechnology Sector to Have Lucrative Opportunities

With annual consumption of 30 billion units of various generic medicines, Iran, the second-biggest consumer of generics in the Asian continent spent over USD 4.5 billion on drugs in 2015. While per capita consumption of generic drugs is three times higher than average per capita consumption in the world, biological medicines and drugs for special diseases suffers from limited access. …

Read More »

Nobel Laureates discuss future researches based on novel drug development

During the 2nd day of Drug Discovery Conference at HCT-Dubai DUBAI – Delegates of the 5th International Conference on Drug Discovery & Therapy and 2nd Biotechnology World Congress attended on the 2nd day plenary lectures by Nobel Laureates and session lectures by eminent scientists. Two illuminating plenary lectures were delivered by Prof. Dr. Ferid Murad, Nobel Laureate, highlighted the discovery …

Read More »

Qatar University pharmacy student scoops international first prize

A Qatar University pharmacy student beat of competition from her peers around the world to secure one of the top prizes at the International Pharmacy Student Federation (IPSF) World Congress. Ghadeer Daghash, a final year undergraduate student at the university’s College of Pharmacy, won first place in the Congress’s senior level patient counseling skills competition. She was one of a …

Read More »

Cold Chain 2012 to Provide Industrialists With Knowledge on Latest Developments in the Food and Pharma Sector

Addressing the most pressing issues in the Middle East region regarding logistics of pharmaceuticals and food material, the Cold Chain 2012 conference commenced yesterday at Habtoor Grand Beach Resort and Spa, Dubai. October 3rd 2012: Habtoor Grand Beach Resort and Spa, Dubai “The MENA region being an arid and high temperate zone, maintaining cold chain in the pharmaceutical and food …

Read More »

NewBridge Pharmaceuticals to Bring Novel Genomic Cancer Tests to Region

NewBridge Pharmaceuticals, a specialty therapeutics company focused on pharmaceuticals,s, biologics, diagnostics and medical devices serving the AfMET markets (Africa, Middle East, Turkey and Caspian regions), today announced that it has entered into an exclusive agreement with Genomic Health, Inc. (NASDAQ: GHDX), a global health company that provides actionable genomic information to personalize genomic health decisions. Through this agreement, Genomic Health …

Read More »

Biomed Analysis: Tackling drug-resistant malaria

Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug’s use must step up, says Priya Shetty. When parasites resistant to the anti-malarial drug artemisinin were discovered along the Thailand-Cambodia border in 2006, it sparked concern but not panic because it appeared to be an isolated pocket of resistance. Now, scientists have found multiple pockets of drug …

Read More »

NGOs call for international regulation of synthetic biology

More than 100 non-governmental organisations (NGOs) have called for greater international oversight of the emerging science of synthetic biology – including a moratorium on the release and commercial use of synthetic organisms and their products until the potential risks are fully understood. Synthetic biology is a broad term covering new approaches to the development of biological functions and systems that …

Read More »

Commitment to the MENA delivers results, with positive outlook for 2012

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, with sales in more than 40 countries across Europe, MENA and the USA, reports its preliminary results for the year ended 31 December 2011. Group revenue increased by 25.6% to $918.0 million, with organic growth of 7.6%, in line with the company’s guidance. Adjusted operating profit grew by …

Read More »

Omnicell to exhibit at Dubai International conference and exhibition

Omnicell will Demonstrate Recently Introduced G4 Medication Automation Platform. Omnicell, Inc., OMCL +0.89% a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will exhibit its state-of-the-art G4 technology at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) March 12-14 at the Dubai International Convention & Exhibition Centre. DUPHAT is one of the most recognized …

Read More »